2008
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. American Journal Of Obstetrics And Gynecology 2008, 200: 75.e1-75.e10. PMID: 18976739, DOI: 10.1016/j.ajog.2008.08.014.Peer-Reviewed Original ResearchConceptsPeptide-specific cytotoxic T lymphocytesCytotoxic T lymphocytesHuman leukocyte antigenLeukocyte antigenOvarian cancerT lymphocytesHuman cytotoxic T-lymphocyte responsesCytotoxic T-lymphocyte precursor frequenciesNatural killer-sensitive targetsPeptide-loaded target cellsType 1 cytokine profileCytotoxic T lymphocyte responsesT lymphocyte precursor frequenciesPotential immunogenic peptidesAdvanced ovarian cancerClass I antibodiesIntracellular cytokine expressionT lymphocyte responsesPositive healthy donorsInterferon-gamma productionT lymphocyte populationsPeripheral blood leukocytesCytokine profileELISPOT assayCytokine expression
1998
Retinoic acid up-regulates the expression of major histocompatibility complex molecules and adhesion/costimulation molecules (specifically, intercellular adhesion molecule ICAM-1) in human cervical cancer
Santin A, Hermonat P, Ravaggi A, Chiriva-Internati M, Pecorelli S, Parham G. Retinoic acid up-regulates the expression of major histocompatibility complex molecules and adhesion/costimulation molecules (specifically, intercellular adhesion molecule ICAM-1) in human cervical cancer. American Journal Of Obstetrics And Gynecology 1998, 179: 1020-1025. PMID: 9790391, DOI: 10.1016/s0002-9378(98)70209-1.Peer-Reviewed Original ResearchMeSH KeywordsBlotting, NorthernFemaleFlow CytometryFluorescent Antibody Technique, IndirectGene Expression Regulation, NeoplasticHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansIntercellular Adhesion Molecule-1RNA, MessengerTretinoinTumor Cells, CulturedUterine Cervical NeoplasmsConceptsMajor histocompatibility complex class IHistocompatibility complex class IComplex class IICAM-1 antigenCervical cancerCervical carcinoma cell linesSurface antigenClass IHuman cervical carcinoma cell lineRetinoic acidCarcinoma cell linesTherapeutic dosesHuman leukocyte antigen (HLA) class IClass II surface antigensCell linesAdhesion molecules ICAM-1Fluorescence-activated cell sorter analysisIntercellular adhesion molecule ICAM-1Additional clinical researchHuman leukocyte antigenMajor histocompatibility complex moleculesAntigen class IMolecules ICAM-1Use of retinoidsUntreated tumor cells